D-0603-2021 Class II Terminated
FDA drug recall D-0603-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Apr 28, 2021 and is designated Class II. Reason for recall: Temperature Abuse: Product exposed to temperature outside specified limits. The recall status is terminated (terminated Sep 17, 2021). Affected quantity: 48 cases.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 16, 2021
- Initiation Date
- Apr 28, 2021
- Termination Date
- Sep 17, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 48 cases
Product description
Sodium Chloride 0.9%, USP, 1000 mL, Mfg by: Fresenius Medical Care North America, Waltham, MA 02451, NDC 46163-0300-10
Reason for recall
Temperature Abuse: Product exposed to temperature outside specified limits.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 20NG02095, Exp. Date October 2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0603-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026